iBio (IBIO) Return on Sales (2011 - 2026)

iBio (IBIO) has 16 years of Return on Sales data on file, last reported at 0.93% in Q1 2026.

• On a quarterly basis, Return on Sales fell 45.0% year-over-year to 0.93% in Q1 2026; TTM through Mar 2026 was 0.93%, a 45.0% decrease from a year earlier, with the FY2025 full-year figure at 2.04%, down 162.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.93%, down from 0.83% in the prior quarter.
• Over the last five years, Return on Sales for IBIO reached as high as 0.03% in Q1 2022 and fell as low as 1.3% in Q4 2023.
• Historically, Return on Sales has averaged 0.5% across 5 years, with a median of 0.26% in 2024.
• Across the five-year window, Return on Sales plunged 105 bps in 2023 and jumped 108 bps in 2024, its largest moves.
• Year by year, Return on Sales stood at 0.25% in 2022, then sank by 411 bps to 1.3% in 2023, then soared by 83 bps to 0.22% in 2024, then slumped by 272 bps to 0.83% in 2025, then fell by 12 bps to 0.93% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.93% in Q1 2026, 0.83% in Q4 2025, and 0.57% in Q3 2025.